XBP1 as a novel molecular target to attenuate drug resistance in hepatocellular carcinoma
Volume 27, Issue 12, July - December 2023, Page 1207-1215 .
Source: Expert Opinion on Therapeutic Targets - Category: Drugs & Pharmacology Authors: Zahra HendiPedram Asadi SarabiDavid HayMassoud Vosougha Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, Academic Center for Education, Culture and Research (ACECR), Tehran, Iranb Dep Source Type: research
More News: Academia | Biology | Cancer & Oncology | Carcinoma | Cytology | Drugs & Pharmacology | Education | Hepatocellular Carcinoma | Liver Cancer | Molecular Biology | Science | Stem Cell Therapy | Stem Cells | Universities & Medical Training